Ison, G. (2018). FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationIson, G. FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationIson, G. FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.